Sartorius Reports Strong Growth in First Half of 2025

Sartorius AG, a key player in the life sciences sector, has announced a continued positive growth trajectory in the first half of 2025. The group achieved a 6.1% increase in sales revenue, amounting to 1,767 million euros. The company's Bioprocess Solutions Division led the charge with an 8.8% increase, driven mainly by consumables. However, the Lab Products & Services Division faced challenges due to cautious investments in laboratory instruments.

The group's underlying EBITDA rose by 11.9% to 527 million euros, and the margin improved to 29.8%. Net profit saw a robust increase of 13.7%, while the employee count experienced a slight rise, reaching 13,685 by mid-year.

Globally, Sartorius observed growth across all regions, with the Americas showing the highest increase at 7.1%. Despite current geopolitical challenges and cost pressures in healthcare, Sartorius remains optimistic in achieving its 2025 targets.

Management reaffirms its guidance for 2025, projecting a 6% growth in sales revenue for the full year, depending on market conditions.